Iroko
develops, commercializes and markets non-narcotic drugs for pain management... Read moreIroko
develops, commercializes and markets non-narcotic drugs for pain management... Read more
President & CEO
Louis J. Vollmer
News
Jun 05, 2026
CEE Legal Matters
Iroko: CMS Advises Iroko Atlas SCPI on Krakow Office Building Acquisition
Dec 29, 2025
Iberian Lawyer
Iroko: Addleshaw Goddard advises Iroko Zen on hotel acquisition
Oct 15, 2025
Property Week
Iroko: Iroko Zen acquires west London office building from Schroders
Mar 02, 2021
The Business Journals: Philadelphia
Iroko: Philadelphia-based blank check company Ibere Pharmaceuticals completes $120M IPO
Nov 30, 2018
BioPortfolio
Iroko: Iroko Pharmaceuticals LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13112018 Prices from USD $250
Oct 31, 2018
The Business Journals
Iroko: Egalet's prescription for a turnaround: Buy 4 Iroko products, file for bankruptcy, reorganize
Oct 31, 2018
www.prnewswire.com
Press Release: Iroko : Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
Sep 30, 2018
BioPortfolio
Iroko: Iroko Pharmaceuticals LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Aug 14, 2018
BioPortfolio
Iroko: Iroko Pharmaceuticals LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
Mar 18, 2018
BioPortfolio
Iroko: Iroko Pharmaceuticals LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12032018 Prices from USD $250
Iroko Competitors
1
2
3
4
5
6
7
8
9